| Literature DB >> 28225035 |
Yue Liu1,2, Yi Wang3, Fengxian Guo1, Lin Zhan1, Toni Mohr3, Prisca Cheng3, Naxin Huo3,4, Ronghui Gu1, Danning Pei1, Jiaqing Sun1, Li Tang1, Chunlin Long1, Luqi Huang2, Yong Q Gu3.
Abstract
Swertia mussotii Franch. is an important traditional Tibetan medicinal plant with pharmacological properties effective in the treatment of various ailments including hepatitis. Secoiridoids are the major bioactive compounds in S. mussotii. To better understand the secoiridoid biosynthesis pathway, we generated transcriptome sequences from the root, leaf, stem, and flower tissues, and performed de novo sequence assembly, yielding 98,613 unique transcripts with an N50 of 1,085 bp. Putative functions could be assigned to 35,029 transcripts (35.52%) based on BLAST searches against annotation databases including GO and KEGG. The expression profiles of 39 candidate transcripts encoding the key enzymes for secoiridoid biosynthesis were examined in different S. mussotii tissues, validated by qRT-PCR, and compared with the homologous genes from S. japonica, a species in the same family, unveiling the gene expression, regulation, and conservation of the pathway. The examination of the accumulated levels of three bioactive compounds, sweroside, swertiamarin, and gentiopicroside, revealed their considerable variations in different tissues, with no significant correlation with the expression profiles of key genes in the pathway, suggesting complex biological behaviours in the coordination of metabolite biosynthesis and accumulation. The genomic dataset and analyses presented here lay the foundation for further research on this important medicinal plant.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28225035 PMCID: PMC5320516 DOI: 10.1038/srep43108
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Overview of transcriptome assembly data showing the size distribution of transcripts.
Figure 2Distribution of transcription factor families.
Figure 3Frequencies and mean expression levels of transcripts matching GO terms.
The percentage of transcripts matching GO terms is shown for each category as red bars.
Figure 4KEGG pathway classification map.
Genes were divided into five branches according to the biological pathways they participated in: (A), Cellular Processes; (B), Environmental Information Processing; (C), Genetic Information Processing; (D), Metabolism; (E), Organismal Systems.
Secondary metabolism pathways in S. mussotii.
| Pathway ID | Pathways | Function categories | SmTc numbers |
|---|---|---|---|
| ko00100 | Steroid biosynthesis | 18 | 31 |
| ko00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 21 | 36 |
| ko00230 | Purine metabolism | 91 | 160 |
| ko00232 | Caffeine metabolism | 2 | 2 |
| ko00400 | Phenylalanine, tyrosine and tryptophan biosynthesis | 23 | 41 |
| ko00860 | Porphyrin and chlorophyll metabolism | 32 | 48 |
| ko00900 | Terpenoid backbone biosynthesis | 28 | 54 |
| ko00901 | Indole alkaloid biosynthesis | 1 | 1 |
| ko00902 | Monoterpenoid biosynthesis | 2 | 4 |
| ko00903 | Limonene and pinene degradation | 2 | 11 |
| ko00904 | Diterpenoid biosynthesis | 8 | 14 |
| ko00905 | Brassinosteroid biosynthesis | 7 | 7 |
| ko00906 | Carotenoid biosynthesis | 21 | 30 |
| ko00908 | Zeatin biosynthesis | 5 | 13 |
| ko00909 | Sesquiterpenoid and triterpenoid biosynthesis | 8 | 14 |
| ko00940 | Phenylpropanoid biosynthesis | 19 | 101 |
| ko00941 | Flavonoid biosynthesis | 14 | 18 |
| ko00942 | Anthocyanin biosynthesis | 3 | 5 |
| ko00944 | Flavone and flavonol biosynthesis | 4 | 4 |
| ko00945 | Stilbenoid, diarylheptanoid and gingerol biosynthesis | 5 | 14 |
| ko00950 | Isoquinoline alkaloid biosynthesis | 9 | 15 |
| ko00960 | Tropane, piperidine and pyridine alkaloid biosynthesis | 8 | 18 |
| ko00965 | Betalain biosynthesis | 2 | 2 |
Figure 5Simple sequence repeats (SSRs) in the S. mussotii transcriptome.
(a) Distribution of different classes of SSRs. (b) Frequency of most abundant SSR motifs.
Figure 6Differential expression analysis of S. mussotii transcripts.
(a) Pair-wise comparisons of different tissues showing DETs. (b) The number of significantly (P-value ≤ 0.05 and at least two-fold change) up- and down- regulated transcripts in each tissue as compared to all three other tissues. (c) Venn diagram representing the number of DETs among S. mussotii tissues.
Figure 7Schematic representation of the proposed swertiamatin biosynthesis pathway and the differential expression of genes involved in the pathway.
(a) Proposed pathway of swertiamatin biosynthesis. (b) The expression of genes involved in the MVA pathway. (c) The expression of genes involved in the MEP pathway. (d) The expression of genes involved in the secoiridoid pathway.
Summary of transcripts in S. mussotii encoding enzymes involved in the secoiridoid pathway.
| Pathway | Gene | Gene name | E.C. number | KO | SmTc |
|---|---|---|---|---|---|
| MVA | ACCT1 | acetyl-CoA C-acetyltransferase | 2.3.1.9 | K00626 | SmTc_2083 |
| ACCT2 | acetyl-CoA C-acetyltransferase | 2.3.1.9 | K00626 | SmTc_5029 | |
| ACCT3 | acetyl-CoA C-acetyltransferase | 2.3.1.9 | K00626 | SmTc_33675 | |
| HMGS1 | hydroxymethylglutaryl-CoA synthase | 2.3.3.10 | K01641 | SmTc_5929 | |
| HMGS2 | hydroxymethylglutaryl-CoA synthase | 2.3.3.10 | K01641 | SmTc_7106 | |
| HMGS3 | hydroxymethylglutaryl-CoA synthase | 2.3.3.10 | K01641 | SmTc_8664 | |
| HMGS4 | hydroxymethylglutaryl-CoA synthase | 2.3.3.10 | K01641 | SmTc_81097 | |
| HMGR1 | hydroxymethylglutaryl-CoA reductase | 1.1.1.34 | K00021 | SmTc_1585 | |
| HMGR2 | hydroxymethylglutaryl-CoA reductase | 1.1.1.34 | K00021 | SmTc_10138 | |
| HMGR3 | hydroxymethylglutaryl-CoA reductase | 1.1.1.34 | K00021 | SmTc_15910 | |
| HMGR4 | hydroxymethylglutaryl-CoA reductase | 1.1.1.34 | K00021 | SmTc_22303 | |
| MVK | mevalonate kinase | 2.7.1.36 | K00869 | SmTc_7721 | |
| PMK | phosphomevalonate kinase | 2.7.4.2 | K00938 | SmTc_5121 | |
| MVD1 | diphosphomevalonate decarboxylase | 4.1.1.33 | K01597 | SmTc_2684 | |
| MVD2 | diphosphomevalonate decarboxylase | 4.1.1.33 | K01597 | SmTc_2834 | |
| MEP | DXS1 | 1-deoxy-D-xylulose-5-phosphate synthase | 2.2.1.7 | K01662 | SmTc_5909 |
| DXS2 | 1-deoxy-D-xylulose-5-phosphate synthase | 2.2.1.7 | K01662 | SmTc_7421 | |
| DXS3 | 1-deoxy-D-xylulose-5-phosphate synthase | 2.2.1.7 | K01662 | SmTc_10119 | |
| DXS4 | 1-deoxy-D-xylulose-5-phosphate synthase | 2.2.1.7 | K01662 | SmTc_13486 | |
| DXR | 1-deoxy-D-xylulose-5-phosphate reductoisomerase | 1.1.1.267 | K00099 | SmTc_8142 | |
| ISPD | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase | 2.7.7.60 | K00991 | SmTc_23281 | |
| ISPE | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 2.7.1.148 | K00919 | SmTc_19780 | |
| ISPF | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 4.6.1.12 | K01770 | SmTc_11729 | |
| GCPE | (E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase | 1.17.7.1 | K03526 | SmTc_845 | |
| ISPH | 4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase | 1.17.7.4 | K03527 | SmTc_757 | |
| IDI1 | isopentenyl-diphosphate delta-isomerase | 5.3.3.2 | K01823 | SmTc_744 | |
| IDI2 | isopentenyl-diphosphate delta-isomerase | 5.3.3.2 | K01823 | SmTc_1157 | |
| GPPS1 | geranyl diphosphate synthase | 2.5.1.1 | K14066 | SmTc_17467 | |
| GPPS2 | geranyl diphosphate synthase | 2.5.1.1 | K14066 | SmTc_6570 | |
| Secoiridoid | GES | geranyl diphosphate diphosphatase | 3.1.7.11 | K20979 | SmTc_70847 |
| G10H | geraniol 10-hydroxylase | 1.14.13.152 | K15099 | SmTc_41455 | |
| 8HGO | 8-hydroxygeraniol oxidoreductase | 1.1.1.324 | SmTc_81115 | ||
| IS | iridoid synthase | 1.3.1.99 | K20144 | SmTc_35128 | |
| IO | iridoid oxidase | SmTc_29298 | |||
| 7-DLGT | 7-deoxyloganetic acid glucosyl transferase | 2.4.1.323 | SmTc_15909 | ||
| DL7H | 7-deoxyloganic acid hydroxylase | SmTc_8300 | |||
| LAMT | loganic acid O-methyltransferase | 2.1.1.50 | SmTc_23275 | ||
| SLS1 | secologanin synthase | 1.3.3.9 | K13400 | SmTc_4315 | |
| SLS2 | secologanin synthase | 1.3.3.9 | K13400 | SmTc_16024 |
Figure 8The expression pattern of seven genes in swertiamarin biosynthesis pathway across different tissues.
R, root; S, stem; L, leaf; F, flower.
Figure 9The content of sweroside, swertiamarin and gentiopicroside in different tissues.
R, root; S, stem; L, leaf; F, flower.